Microsoft word - ms-12-903_jan 2013 adv. pdl updates member flier_final
Updates to your prescription benefits Effective Jan. 1, 2013 for your Advantage PDL
Within the Prescription Drug List (PDL), medications are grouped by tier. The tier indicates the amount you pay when you fill a prescription. Please reference this chart as you review the following updates. Most options listed are available in Tier 1, your lowest-cost option.
If your medication is listed below, you may continue taking it, but you may pay a higher cost. We encourage you to discuss the listed lower-cost option(s) that may also treat your condition with your doctor. Medications moving to a higher tier Medications may move from a lower tier to a higher tier when they are more costly and have available lower-cost options.
Therapeutic Use Medication Name Tier Placement Lower-Cost Options Osteoporosis
alendronate (generic Fosamax), ibandronate (generic Boniva)
oxybutynin (generic Ditropan), oxybutynin sustained-release
Overactive Bladder
(generic Ditropan XL), trospium (generic Sanctura), Sanctura XR, Vesicare
Thyroid Hormone Replacement Viral Infection
podofilox liquid (generic Condylox liquid)
Medication being added to the Select Designated Pharmacy (SDP) Program Through this program, you must choose one of three options to continue to receive network benefits. Call the Pharmacy Customer Service member telephone number on the back of your health plan ID card to determine if this program applies to your benefit plan. This program currently applies to New York small and large group fully insured groups only. Therapeutic Use Medication Name Tier Placement Lower-Cost Options
Depression Diagnosis: citalopram (generic Celexa), fluoxetine (generic Prozac), sertraline (generic Zoloft), venlafaxine
Depression
sustained-release (generic Effexor XR), Pristiq Neuropathic Pain Diagnosis: gabapentin (generic Neurontin)
Medications excluded from benefit coverage We evaluate medications based on their total value, including how a medication works and how much it costs. When several medications work in the same way, we may choose to exclude prescription drug products that are comprised of components available in over-the-counter form or equivalent. The medications listed below are not covered under the pharmacy benefit plan. Therapeutic Use Medication Name Lower-Cost Options Ulcers, Heartburn
OTC Zegerid, omeprazole (generic Prilosec), pantoprazole (generic Protonix)
and Reflux Medications that require precertification (Connecticut and New York only) The medications listed below require your physician to provide additional prescribing information to determine if coverage is available. Therapeutic Use Medication Name Lower-Cost Options
sulfacetamide sodium/sulfur (generic Sulfatol)
Contraceptive
Gildess FE, Junel FE, Microgestin FE (generics for Loestrin FE)
Depression Erectile Dysfunction
OTC ketotifen (Zaditor), azelastine ophthalmic solution (generic Optivar),
Eye Allergies
bromfenac (generic Xibrom), ketorolac (generic Acular)
Hepatitis C
amlodipine (generic Norvasc) plus losartan (generic Cozaar)
amlodipine (generic Norvasc) plus Benicar or Micardis
amlodipine (generic Norvasc) plus Diovan
High Blood Pressure
amlodipine (generic Norvasc) plus losartan/hydrochlorothiazide
amlodipine (generic Norvasc) plus Benicar HCT or Micardis HCT
amlodipine (generic Norvasc) plus Diovan HCT
High Cholesterol Inflammation
prednisolone (generic Prelone), Orapred, Pediapred
Nasal Allergies
azelastine nasal spray (generic Astelin), Astepro
Neuropathic Pain
tramadol extended-release (generic Ultram ER), tramadol immediate-release
ibuprofen (generic Motrin) plus OTC famotidine (generic Pepcid AC)
chlorzoxazone (generic Parafon Forte DSC)
chlorzoxazone (generic Parafon Forte DSC), cyclobenzaprine (generic Flexeril),
metaxalone (generic Skelaxin), methocarbamol (generic Robaxin)
Psoriasis Restless Legs Syndrome
metronidazole gel 0.75% (generic Metrogel)
metronidazole gel 0.75% (generic Metrogel)
Skin Conditions (Other)
hydrocortisone/pramoxine (generic Analpram E)
Toenail Infections
1. For impacted plans, these medications may also move to the highest tier based on the benefit plan (Tier 4). Please refer to Rider language to determine exclusion status. For Connecticut and New York, medications may be excluded unless medically necessary. 2. These medications were excluded at launch in Connecticut and New York (unless medically necessary) - precertification may already be in place. They are covered in New Jersey.
For more information For questions about your pharmacy benefit, please visit oxfordhealth.com or call the Pharmacy
Customer Service member telephone number on the back of your health plan ID card. If you are hearing impaired and require assistance, please call our TTY/TDD line at 1-800-201-4875. Please call 1-800-303-6719 for assistance in Chinese, 1-800-544-4249 for assistance in Korean, or the telephone number on your health plan ID card for assistance in English and other languages.
2012 Oxford Health Plans LLC. All rights reserved. Confidential Information. Do not reproduce or redistribute without the express permission of UnitedHealth Group. This does not apply to UnitedHealthcare WEST business administered by Prescription Solutions by OptumRx. UnitedHealthcare® and the dimensional U logo are registered marks owned by UnitedHealth Group Incorporated. All branded medications are trademarks or registered trademarks of their respective owners. Please note not all PDL updates apply to all groups depending on state regulations, Riders and Summary Plan Descriptions (SPDs). For Internal Use Only. Oxford HMO products are underwritten by Oxford Health Plans (NY), Inc., Oxford Health Plans (NJ), Inc. and Oxford Health Plans (CT), Inc. Oxford insurance products are underwritten by Oxford Health Insurance, Inc.
To the Staff and our Clients at Southampton Health Services regarding two “new” appetite suppressants;The U.S. Food and Drug Administration (FDA) recently approved two “new” weight-loss drugs , Belviq and Qsymia . It was done, not because these medications are particularly unique or more effective, but because the FDA has not approved anything in the past 13 years to help decrease our na
Green Shield Prescription Drug Plan (A brief Overview) Effective January 1, 2009 The prescription drug co-pay for actives and retirees will increase to 10% per prescription with a maximum per family of $250 for the 2009 year . Once the yearly maximum co-pay is reached the active employee or retiree and any of their covered dependents will no longer be required to pay a